Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
How-To Geek on MSN
The easiest way to build a local dev toolbox with one file
Keep your host free from lingering services and mismatched versions. Run your dev stack in isolation and rebuild it when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results